entertainment -WSS

entertainment

author：hotspot 2025-09-27 09:40:39 - browse：3

Adobe

The Food and Drug Administration has cleared Otsuka Pharmaceutical’s digital treatment for major depressive disorder, offering a new option for millions of people who struggle with the stubborn mental health condition.

Called Rejoyn, the smartphone-based treatment for major depressive disorder symptoms was developed with digital health company Click Therapeutics, and it is intended for use by prescription alongside antidepressants. The six-week program delivers a novel “cognitive-emotional training” technique, in which people are asked to identify and recall faces showing different emotions. Researchers hypothesize that the technique targets the brain’s dorsolateral prefrontal cortex and the amygdala and may “enhance cognitive control over emotional information processing.” Patients also receive cognitive behavioral therapy.

Rejoyn has been in development since 2018, and Otsuka is the first drug company to receive FDA clearance for a digital treatment for a mental health condition. But that landmark comes amid many questions about whether such digital therapeutics deliver their advertised results — and whether they can gain traction with clinicians, insurers, and patients. Prescription digital therapeutics have yet to see a blockbuster success, and several companies have gone out of business trying to create one.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： It was time to plan for my old age. If only I could stop crying

WSS

2 officers injured in shooting in Orlando, police say

Group behind ProMed defends move to subscription

CDC recommends RSV monoclonal antibody for infants

'Brian's Song' at 50 still offers lessons about cancer for today

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Paxlovid rebound happens. Why and to whom are still a mystery

leisure time

entertainment

knowledge

Jerome Adams on the need for new antivirals for Covid

Late stage cancers on the rise after pandemic delayed screenings

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

A controversial new treatment promises to make little people taller

Sports medicine is finally prioritizing gender equality

Restaurant meals are packed with calories, and we still keep eating them

After affirmative action ruling, medical educators look to 'holistic review'

Sweden knocks USA out of World Cup in penalty kicks

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Personalized medicine goes far beyond genetics

hotspot

Kansas bar where gunfire wounded 9 last month closes permanently

'Null' research findings aren't empty of meaning. Let's publish them

When waiting feels immoral: Empathy in the emergency department

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

How CRISPR works, explained in two minutes

leisure time

Wikipedia

Wikipedia

leisure time